172 related articles for article (PubMed ID: 16141353)
1. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation.
Heimpel H; Schwarz K; Ebnöther M; Goede JS; Heydrich D; Kamp T; Plaumann L; Rath B; Roessler J; Schildknecht O; Schmid M; Wuillemin W; Einsiedler B; Leichtle R; Tamary H; Kohne E
Blood; 2006 Jan; 107(1):334-40. PubMed ID: 16141353
[TBL] [Abstract][Full Text] [Related]
2. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.
Heimpel H; Anselstetter V; Chrobak L; Denecke J; Einsiedler B; Gallmeier K; Griesshammer A; Marquardt T; Janka-Schaub G; Kron M; Kohne E
Blood; 2003 Dec; 102(13):4576-81. PubMed ID: 12933587
[TBL] [Abstract][Full Text] [Related]
3. Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
Niss O; Lorsbach RB; Berger M; Chonat S; McLemore M; Buchbinder D; McCavit T; Shaffer LG; Simpson J; Schwartz JH; Meznarich J; Emberesh M; Seu KG; Zhang W; Kalfa TA;
Blood Cells Mol Dis; 2021 Mar; 87():102534. PubMed ID: 33401150
[TBL] [Abstract][Full Text] [Related]
4. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.
Roy NBA; Babbs C
Br J Haematol; 2019 May; 185(3):436-449. PubMed ID: 30836435
[TBL] [Abstract][Full Text] [Related]
6. Congenital dyserythropoietic anemia in a Chinese family with a mutation of the CDAN1-gene.
Ru YX; Zhu XF; Yan WW; Gao JT; Schwarz K; Heimpel H
Ann Hematol; 2008 Sep; 87(9):751-4. PubMed ID: 18575862
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I.
Shalev H; Al-Athamen K; Levi I; Levitas A; Tamary H
Eur J Haematol; 2017 Jan; 98(1):13-18. PubMed ID: 27206021
[TBL] [Abstract][Full Text] [Related]
8. Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.
Meznarich JA; Draper L; Christensen RD; Yaish HM; Luem ND; Pysher TJ; Jung G; Nemeth E; Ganz T; Ward DM
Blood Cells Mol Dis; 2018 Jul; 71():63-66. PubMed ID: 29599085
[TBL] [Abstract][Full Text] [Related]
9. Natural history of congenital dyserythropoietic anemia type II.
Iolascon A; Delaunay J; Wickramasinghe SN; Perrotta S; Gigante M; Camaschella C
Blood; 2001 Aug; 98(4):1258-60. PubMed ID: 11493480
[TBL] [Abstract][Full Text] [Related]
10. Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.
Fujino H; Doisaki S; Park YD; Hama A; Muramatsu H; Kojima S; Sumimoto S
Int J Hematol; 2013 May; 97(5):650-3. PubMed ID: 23605369
[TBL] [Abstract][Full Text] [Related]
11. Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.
Yarali N; Fişgin T; Duru F; Atilla P; Müftüoğlu SF; Kaymaz SF
Pediatr Hematol Oncol; 2005 Jun; 22(4):265-70. PubMed ID: 16020112
[TBL] [Abstract][Full Text] [Related]
12. New Cases and Mutations in
Musri MM; Venturi V; Ferrer-Cortès X; Romero-Cortadellas L; Hernández G; Leoz P; Ricard Andrés MP; Morado M; Fernández Valle MDC; Beneitez Pastor D; Ortuño Cabrero A; Moreno Gamiz M; Senent Peris L; Perez-Valencia AI; Pérez-Montero S; Tornador C; Sánchez M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373084
[TBL] [Abstract][Full Text] [Related]
13. Congenital dyserythropoietic anemia type I: report of a case.
Kumar A; Kushwaha R; Singh US
Indian J Hematol Blood Transfus; 2014 Mar; 30(1):48-50. PubMed ID: 24554823
[TBL] [Abstract][Full Text] [Related]
14. Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.
Rathe M; Møller MB; Greisen PW; Fisker N
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049846
[TBL] [Abstract][Full Text] [Related]
15. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
Heimpel H
Ann Hematol; 2004 Oct; 83(10):613-21. PubMed ID: 15278299
[TBL] [Abstract][Full Text] [Related]
16. alpha-Interferon therapy for congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Blanc P; Navarro R; Saghroun M; Vannereau H; Braun M; Wagner A; Taïb J; Lavabre-Bertrand C; Navarro M
Br J Haematol; 1995 Apr; 89(4):929-32. PubMed ID: 7772538
[TBL] [Abstract][Full Text] [Related]
17. Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension with pigeon chest deformity.
El-Sheikh AA; Hashem H; Holman C; Vyas YM
Pediatr Blood Cancer; 2014 Aug; 61(8):1460-2. PubMed ID: 24420417
[TBL] [Abstract][Full Text] [Related]
18. Treatment of transfusion-dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha-2a.
Abu-Quider A; Asleh M; Shalev H; Fruchtman Y; Ben-Harosh M; Beck G; Kapelushnik J
Eur J Haematol; 2020 Aug; 105(2):216-222. PubMed ID: 32302424
[TBL] [Abstract][Full Text] [Related]
19. Congenital dyserythropoietic anemia in China: a case report from two families and a review.
Ru Y; Liu G; Bai J; Dong S; Nie N; Zhang H; Zhao S; Zheng Y; Zhu X; Nie G; Zhang F; Eyden B
Ann Hematol; 2014 May; 93(5):773-7. PubMed ID: 24196372
[TBL] [Abstract][Full Text] [Related]
20. Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b.
Roda L; Pasche J; Fournier A; Terorotua V; Wickramasinghe SN; Tamary H; Schischmanoff PO; Tchernia G; Delaunay J
J Pediatr Hematol Oncol; 2002; 24(6):503-6. PubMed ID: 12218603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
